349 related articles for article (PubMed ID: 19476346)
1. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
4. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT
J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
6. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system.
Blum FC; Chen C; Kroken AR; Barbieri JT
Infect Immun; 2012 May; 80(5):1662-9. PubMed ID: 22392932
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
Peng L; Tepp WH; Johnson EA; Dong M
PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
[TBL] [Abstract][Full Text] [Related]
8. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
Rummel A
Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
[TBL] [Abstract][Full Text] [Related]
9. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
10. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.
Zhang Y; Gardberg AS; Edwards TE; Sankaran B; Robinson H; Varnum SM; Buchko GW
Biochimie; 2013 Jul; 95(7):1379-85. PubMed ID: 23523511
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.
Benoit RM; Frey D; Hilbert M; Kevenaar JT; Wieser MM; Stirnimann CU; McMillan D; Ceska T; Lebon F; Jaussi R; Steinmetz MO; Schertler GF; Hoogenraad CC; Capitani G; Kammerer RA
Nature; 2014 Jan; 505(7481):108-11. PubMed ID: 24240280
[TBL] [Abstract][Full Text] [Related]
14. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
Atassi MZ; Taruishi M; Naqvi M; Steward LE; Aoki KR
Protein J; 2014 Jun; 33(3):278-88. PubMed ID: 24740609
[TBL] [Abstract][Full Text] [Related]
15. Association of botulinum neurotoxins with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Toxicon; 2009 Oct; 54(5):570-4. PubMed ID: 19362106
[TBL] [Abstract][Full Text] [Related]
16. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.
Mahrhold S; Bergström T; Stern D; Dorner BG; Åstot C; Rummel A
Biochem J; 2016 Sep; 473(17):2645-54. PubMed ID: 27313224
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of botulinum neurotoxin type G receptor binding .
Schmitt J; Karalewitz A; Benefield DA; Mushrush DJ; Pruitt RN; Spiller BW; Barbieri JT; Lacy DB
Biochemistry; 2010 Jun; 49(25):5200-5. PubMed ID: 20507178
[TBL] [Abstract][Full Text] [Related]
18. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E.
Mahrhold S; Strotmeier J; Garcia-Rodriguez C; Lou J; Marks JD; Rummel A; Binz T
Biochem J; 2013 Jul; 453(1):37-47. PubMed ID: 23621114
[TBL] [Abstract][Full Text] [Related]
19. SV2 is the protein receptor for botulinum neurotoxin A.
Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A
Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]